Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per thor Straten

Showing results (51-60 of 157) with videos related to

Pageof 16
Sort By:
Cancer Immunology, Immunotherapy : CII|September 2, 2006
T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cellsJon Amund Kyte, Gunnar Kvalheim, Kari Lislerud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
The immunogenicity of the hTERT540-548 peptide in cancerLynn Wenandy, Rikke Baek Sørensen, Lisa Sengeløv, et al.
Cancer Immunology, Immunotherapy : CII|September 18, 2014
Successful treatment with Ipilimumab and Interleukin-2 in two patients with metastatic melanoma and systemic autoimmune diseaseMagnus Pedersen, Rikke Andersen, Peter Nørgaard, et al.
Cancer Immunology, Immunotherapy : CII|January 13, 2012
Generation of autologous tumor-specific T cells for adoptive transfer based on vaccination, in vitro restimulation and CD3/CD28 dynabead-induced T cell expansionMarie Klinge Brimnes, Anne Ortved Gang, Marco Donia, et al.
International Immunology|April 1, 2006
Reactivity of naive CD4+CD25- T cells against gut microflora in healthy miceMonika Gad, Dorthe Lundsgaard, Stine Kjellev, et al.
Cancer Immunology, Immunotherapy : CII|July 20, 2006
Efficient tumor cell lysis mediated by a Bcl-X(L) specific T cell clone isolated from a breast cancer patientRikke Baek Sørensen, Sine Reker Hadrup, Tania Køllgaard, et al.
Cancer Biology & Therapy|April 4, 2006
Persistence of survivin specific T cells for seven years in a melanoma patient during complete remissionSine Reker Hadrup, Julie Gehl, Rikke Baek Sørensen, et al.
Cancer Immunology, Immunotherapy : CII|February 21, 2008
Cancer treatment: the combination of vaccination with other therapiesMads Hald Andersen, Rikke Baek Sørensen, David Schrama, et al.
European Journal of Immunology|April 2, 2009
Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopesUta B Hofmann, Heike Voigt, Mads H Andersen, et al.
Oncoimmunology|September 18, 2018
Chemokine receptor engineering of T cells with CXCR2 improves homing towards subcutaneous human melanomas in xenograft mouse modelManja Idorn, Signe Koggersbøl Skadborg, Lauge Kellermann, et al.
Pageof 16

Showing results (51-60 of 157) with videos related to

Sort By:
Pageof 16
Cancer Immunology, Immunotherapy : CII|September 2, 2006
T cell responses in melanoma patients after vaccination with tumor-mRNA transfected dendritic cellsJon Amund Kyte, Gunnar Kvalheim, Kari Lislerud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
The immunogenicity of the hTERT540-548 peptide in cancerLynn Wenandy, Rikke Baek Sørensen, Lisa Sengeløv, et al.
Cancer Immunology, Immunotherapy : CII|September 18, 2014
Successful treatment with Ipilimumab and Interleukin-2 in two patients with metastatic melanoma and systemic autoimmune diseaseMagnus Pedersen, Rikke Andersen, Peter Nørgaard, et al.
Cancer Immunology, Immunotherapy : CII|January 13, 2012
Generation of autologous tumor-specific T cells for adoptive transfer based on vaccination, in vitro restimulation and CD3/CD28 dynabead-induced T cell expansionMarie Klinge Brimnes, Anne Ortved Gang, Marco Donia, et al.
International Immunology|April 1, 2006
Reactivity of naive CD4+CD25- T cells against gut microflora in healthy miceMonika Gad, Dorthe Lundsgaard, Stine Kjellev, et al.
Cancer Immunology, Immunotherapy : CII|July 20, 2006
Efficient tumor cell lysis mediated by a Bcl-X(L) specific T cell clone isolated from a breast cancer patientRikke Baek Sørensen, Sine Reker Hadrup, Tania Køllgaard, et al.
Cancer Biology & Therapy|April 4, 2006
Persistence of survivin specific T cells for seven years in a melanoma patient during complete remissionSine Reker Hadrup, Julie Gehl, Rikke Baek Sørensen, et al.
Cancer Immunology, Immunotherapy : CII|February 21, 2008
Cancer treatment: the combination of vaccination with other therapiesMads Hald Andersen, Rikke Baek Sørensen, David Schrama, et al.
European Journal of Immunology|April 2, 2009
Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopesUta B Hofmann, Heike Voigt, Mads H Andersen, et al.
Oncoimmunology|September 18, 2018
Chemokine receptor engineering of T cells with CXCR2 improves homing towards subcutaneous human melanomas in xenograft mouse modelManja Idorn, Signe Koggersbøl Skadborg, Lauge Kellermann, et al.
Pageof 16